- Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
-
Sugimoto K, Kamiyama N, Kakegawa T, Takahashi H, Wada T, Abe M, Yoshimasu Y, Takeuchi H, Itoi T
- KMID: 2543375
- Ultrasonography.
- 2023 Jul;42(3):388-399.
- doi: 10.14366/usg.23065
This review outlines several modified versions of the contrast-enhanced ultrasonography Liver Imaging Reporting and Data System (CEUS LI-RADS) that utilize Sonazoid. Furthermore, it discusses the advantages and challenges of diagnosing... -
- CITED
-
- Close
- SHARE
-
- Close
- Irreversible electroporation of hepatocellular carcinoma: the role of ultrasonography
-
Sugimoto K, Abe M, Yoshimasu Y, Takeuchi H, Kasai Y, Itoi T
- KMID: 2503190
- Ultrasonography.
- 2020 Jul;39(3):229-237.
- doi: 10.14366/usg.20023
Irreversible electroporation (IRE) is a novel form of soft tissue ablation therapy that uses highcurrent electrical pulses to induce the formation of pores in the cell membrane, leading to cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical utilization of shear wave dispersion imaging in diffuse liver disease
-
Sugimoto K, Moriyasu F, Oshiro H, Takeuchi H, Yoshimasu , Kasai Y, Itoi T
- KMID: 2501426
- Ultrasonography.
- 2020 Jan;39(1):3-10.
- doi: 10.14366/usg.19031
Shear wave (SW) dispersion imaging is a newly developed imaging technology for assessing the dispersion slope of SWs, which is related to tissue viscosity in diffuse liver disease. Our preclinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Sentinel Node Navigation Surgery for Early Gastric Cancer
-
Booka E, Takeuchi H
- KMID: 2539477
- J Gastric Cancer.
- 2023 Jan;23(1):159-170.
- doi: 10.5230/jgc.2023.23.e4
Maintaining the postoperative quality of life (QOL) while ensuring curability without overtreatment is important in the treatment of early gastric cancer. Postoperative QOL is anticipated to be maintained through minimally... -
- CITED
-
- Close
- SHARE
-
- Close
- Genomic Profiling Shows Increased Glucose Metabolism in Luminal B Breast Cancer
-
Ueda S, Saeki T, Takeuchi H, Shigekawa , Matsuura K, Nakamiya N, Sano H, Shimada H, Hirokawa E, Osaki A
- KMID: 2286387
- J Breast Cancer.
- 2013 Sep;16(3):342-344.
- doi: 10.4048/jbc.2013.16.3.342
We had previously reported a close association between pathological response and the maximum tumor standardized uptake value (SUVmax) measured by 18F-fluorodeoxyglucose positron emission tomography prior to chemotherapy in estrogen receptor... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status and Future Perspectives on Minimally Invasive Esophagectomy
-
Kawakubo H, Takeuchi H, Kitagawa Y
- KMID: 1967091
- Korean J Thorac Cardiovasc Surg.
- 2013 Aug;46(4):241-248.
Esophageal cancer has one of the highest malignant potentials of any type of tumor. The 3-field lymph node dissection is the standard procedure in Japan for surgically curable esophageal cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Factor Structure of the Targeted Inventory on Problems in Schizophrenia
-
Tanaka S, Nagase T, Suzuki T, Nomura K, Takeuchi H, Nakajima S, Uchida H, Yagi G, Watanabe K, Mimura M
- KMID: 2171192
- Clin Psychopharmacol Neurosci.
- 2013 Apr;11(1):18-23.
OBJECTIVE: The aim of this study was to explore the factor structure of a novel, 10-item rating scale, the Targeted Inventory on Problems in Schizophrenia (TIP-Sz). Determining the factor structure... -
- CITED
-
- Close
- SHARE
-
- Close
- A novel mechanism of bitter taste transduction
-
Kaneko A, Takeuchi H, Kurahashi , Tsunenari
- KMID: 2071546
- Korean J Physiol Pharmacol.
- 1999 Oct;3(5):455-459.
Bitter taste is an important warning sign for animals that food is poisonous. The transduction mechanism of bitter taste is still a contradictory matter among researchers. The major current hypothesis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
-
Masaoka T, Kameyama H, Yamane T, Yamamoto Y, Takeuchi H, Suzuki H, Kitagawa Y, Kanai T
- KMID: 2422848
- J Neurogastroenterol Motil.
- 2018 Oct;24(4):577-583.
- doi: 10.5056/jnm18036
BACKGROUND/AIMS: Potassium-competitive acid blockers are expected to be the next generation of drugs for the treatment of diseases caused by gastric acid. In 2015, vonoprazan fumarate, a novel potassium-competitive acid... -
- CITED
-
- Close
- SHARE
-
- Close
